Retatrutide is considered the most advanced metabolic peptide currently in research, activating three hormone pathways at once — GLP-1, GIP, and glucagon. This “triple action” goes a step further than Tirzepatide by also targeting glucagon receptors, which are linked to fat breakdown and energy expenditure. Early research has shown some of the most significant body-weight changes observed in this class of compounds to date.
Researched for: appetite regulation, fat metabolism, energy expenditure, body composition
For Research Purposes Only. Not for human or animal consumption.
